Given its critical role in maintaining genomic stability, RECQL4 is being investigated as a potential therapeutic target in cancer treatment. Strategies to modulate RECQL4 activity could potentially enhance the efficacy of existing cancer therapies, particularly those that induce DNA damage, such as radiation and certain chemotherapies. However, further research is needed to fully understand the therapeutic potential and to develop targeted treatments.
